Current Position: Product Center
Anti-IGF1R hIgG1 Reference Antibody (Dalobio)
Cat. No.
GM-87749MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No:GM-87749MAB

Product:Anti-IGF1R hIgG1 Reference Antibody (Dalobio)



Cat. No. & Size

GM-87749MAB-1mg / 1 mg

GM-87749MAB-5mg / 5 mg

GM-87749MAB-25mg / 25 mg

GM-87749MAB-50mg / 50mg

GM-87749MAB-100mg / 100 mg




Description

Expression System        CHO

Aggregation                      < 5% as determined by SEC-HPLC

Purity                                 > 95% as determined by SDS-PAGE

Endotoxin                         < 1 EU/mg, determined by LAL gel clotting assay

Sterility                              0.2 μm Filtered

Target                               IGF1R

Clone                                 Dalotuzumab

Alternative Names         CD221, IGFIR, IGFR, JTK13

Source/Isotype                Monoclonal Human IgG1 (K214R/D356E/L358M), Kappa

Application                       /

Description                   The IGF1R gene encodes the Insulin-like Growth Factor 1 Receptor (IGF1R), which belongs to the receptor tyrosine kinase (RTK) family. Dalotuzumab (MK-0646), developed by Merck, is a humanized monoclonal antibody specifically targeting IGF1R, aiming to block the pro-proliferative and anti-apoptotic effects of IGF-1 on cancer cells.

Formulation                    phosphate-buffered solution, pH 7.4.



Data

image.png

image.png


Anti-IGF1R hIgG1 Reference Antibody (Dalobio)
Cat. No.
GM-87749MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No:GM-87749MAB

Product:Anti-IGF1R hIgG1 Reference Antibody (Dalobio)



Cat. No. & Size

GM-87749MAB-1mg / 1 mg

GM-87749MAB-5mg / 5 mg

GM-87749MAB-25mg / 25 mg

GM-87749MAB-50mg / 50mg

GM-87749MAB-100mg / 100 mg




Description

Expression System        CHO

Aggregation                      < 5% as determined by SEC-HPLC

Purity                                 > 95% as determined by SDS-PAGE

Endotoxin                         < 1 EU/mg, determined by LAL gel clotting assay

Sterility                              0.2 μm Filtered

Target                               IGF1R

Clone                                 Dalotuzumab

Alternative Names         CD221, IGFIR, IGFR, JTK13

Source/Isotype                Monoclonal Human IgG1 (K214R/D356E/L358M), Kappa

Application                       /

Description                   The IGF1R gene encodes the Insulin-like Growth Factor 1 Receptor (IGF1R), which belongs to the receptor tyrosine kinase (RTK) family. Dalotuzumab (MK-0646), developed by Merck, is a humanized monoclonal antibody specifically targeting IGF1R, aiming to block the pro-proliferative and anti-apoptotic effects of IGF-1 on cancer cells.

Formulation                    phosphate-buffered solution, pH 7.4.



Data

image.png

image.png


Message consultation
reset
submit
Message
Message consultation
reset
submit